[1]Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CAA Cancer J Clin,2012, 62(1):10-29.
[2]Feng XN,Yi TT.Expression and clinical significance of CD105 in epithelial ovarian cancer[J].Heilongjiang Medicing and Pharmacy,2013,36(6):17-18. (in Chinese)
冯晓娜,衣甜甜.血管内皮增殖标志物CD105在上皮性卵巢癌血清中的表达水平及意义[J].黑龙江医药科学,2013,36(6):17-18.
[3]Kuhn E,Kurman RJ,Sehdev AS,et al.Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma [J].Int J Gynecol Pathol,2012,31(5):416-422
[4]Liu P, Sun YL, Du J, et al. CD105/Ki67 co-expression correlates with tumor progression and poor prognosis in epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2012, 22(4):586-592.
[5]Perez-Gómez E, Del Castillo G, Juan Francisco S, et al. The role of the TGF-β coreceptor endoglin in cancer[J]. Scientific World Journal, 2010, 10:2367-2384.
[6]Marioni G, Staffieri A, Manzato E, et al. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma[J].Arch Otolaryngol Head Neck Surg, 2011, 137(2):175-180.
[7]Nieman KM,Kenny HA,Penicka CV,et al.Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth[J].Nat Med,2011,17(11):1498-1503.
[8]Vaughan S,Coward JI,Bast RC,et al.Rethinking ovarian cancer: recommendations for improving outcomes [J].Nat Rev Cancer,2011,11(10):719-725.
[9]Zillhardt M,Park SM,Romero IL,et al.Foretinib (GSK 1363089),an orally available multikinase inhibitor of c-Met and VEGFR-2,blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis [J].Clin Cancer Res,2011,17(12):4042-4051.
[10]Senol EP, Tasdelen I, Adim SB, et al. A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer[J]. Bratisl Lek Listy, 2013, 114(11):645-649.
[11]McCall CM, Shi C, Cornish TC, et al. Grading of welldifferentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate[J]. Am J Surg Pathol, 2013,37(11):1671-1677.
[12]Heim S, Beschorner R, Mittelbronn M, et al. Increasedmitotic and proliferative activity are associatedwith worse prognosis in papillary tumors of thepineal region[J].Am J Surg Pathol, 2014, 38(1):106-110.
[13]Gu JX,Zhang ZhX. Relationship between CD105 and malignant tumor [J].Contemporary Medicine,2015,21(12):16-17. (in Chinese)
顾金霞,张振新.CD105与恶性肿瘤的关系[J].当代医学,2015,21(12):16-17.
|